GTR 83464134
Bids Are Invited For This Term Of Reference Aims To List The Technical Requirements For Purchasing The Medication Mepolizumab 100 MgMl - Injectable Solution, With The Purpose Of Serving Patients Registered In The Specialized Pharmaceutical Assistance Component (Ceaf), In Accordance With SctieMs Ordinance No. 14, Of August 24, 2021, Which Approves The Clinical Protocol And Therapeutic Guidelines For The Treatment Of Asthma. The Specialized Component Of Pharmaceutical Assistance (Ceaf) Is A Strategy For Access To Medicines Within The Scope Of The Unified Health System (Sus), Characterized By The Search To Guarantee The Completeness Of Drug Treatment, On An Outpatient Basis, Whose Lines Of Care Are Defined In Clinical Protocols And Therapeutic Guidelines (Pcdt), Published By The Ministry Of Health. This Component Is Regulated By GmMs Consolidation Ordinances Nº 2 And 6, Of 09282017, Exclusively Serving Patients Who Meet The Criteria Established In Their Protocol... Continue Reading >
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
83464134
Tendering Authority
Subscribe to view
Tender No
040/24/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For This Term Of Reference Aims To List The Technical Requirements For Purchasing The Medication Mepolizumab 100 MgMl - Injectable Solution, With The Purpose Of Serving Patients Registered In The Specialized Pharmaceutical Assistance Component (Ceaf), In Accordance With SctieMs Ordinance No. 14, Of August 24, 2021, Which Approves The Clinical Protocol And Therapeutic Guidelines For The Treatment Of Asthma. The Specialized Component Of Pharmaceutical Assistance (Ceaf) Is A Strategy For Access To Medicines Within The Scope Of The Unified Health System (Sus), Characterized By The Search To Guarantee The Completeness Of Drug Treatment, On An Outpatient Basis, Whose Lines Of Care Are Defined In Clinical Protocols And Therapeutic Guidelines (Pcdt), Published By The Ministry Of Health. This Component Is Regulated By GmMs Consolidation Ordinances Nº 2 And 6, Of 09282017, Exclusively Serving Patients Who Meet The Criteria Established In Their Protocol... Continue Reading >
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
09-08-2024
Closed
Work Detail
Pharmacological Group: Monoclonal Antibody, Active Ingredient: Mepolizumab, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 100, Unit: Mg, Volume: N/A, Presentation: N/A, Accessory: N/A, Supply Form: Unit
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
30528c75-4666-4ab1-bc6e-4b6a4e417670.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.